29 web-programmer-developer-"https:" "UCL" Postgraduate positions at University of Oxford
Sort by
Refine Your Search
-
. Please note the eligibility criteria set out by the UKRI at: https://www.ukri.org/what-we-do/developing-people-and-skills/esrc/funding-for-postgraduate-training-and-development/eligibility-for-studentship
-
Research Council rate (currently set at £20,780 p.a.) for 3.5 years. Please note the eligibility criteria set out by the UKRI at: https://www.ukri.org/what-we-do/developing-people-and-skills/esrc/funding
-
Ertegun Graduate Scholarship Programme in the Humanities The Mica and Ahmet Ertegun Graduate Scholarship Programme funds full-time graduate degrees in various subjects within the Humanities
-
research programme CoTide: Co-design to deliver Scalable Tidal Stream Energy. CoTide is developing and demonstrating new solutions and integrated tools and design processes for tidal stream energy that will
-
an attractive range of competitive benefits available to all staff for both work and personal life - https://hr.admin.ox.ac.uk/staff-benefits For informal enquiries about the post, please contact - Professor
-
Crankstart Graduate Scholarship The Crankstart Scholarships provide a programme of enhanced support for UK residents from lower-income households to undertake undergraduate study at Oxford. This is
-
funded by the University and by NaturalMotion Ltd. NaturalMotion Ltd develops computational methods for animating movement, as used in Hollywood films and computer games. The founder, Torsten Reil, is an
-
and the Thatcher Development Programme at Somerville College. The late Lady Thatcher studied Chemistry at Somerville College Oxford from 1943 to 1946 and received bursary and scholarship support from
-
was established in Japan in 1987 with the aim of contributing to the development of society through the promotion of ethics-related academic research, and educational and socio-cultural activities. The scholarships
-
recognises his pivotal role in work that led, among others, to the development of CAMPATH monoclonal antibodies, which are now used for the treatment of certain leukaemias and for multiple sclerosis